Carmen Guillén-Ponce

9PUBLICATIONS
36CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 14, 2024
A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial.

Francesca Sarno, Jair Tenorio, Sofia Perea

|Sep 28, 2024
Constitutional Mutation of PIK3CA: A Variant of Cowden Syndrome?

Elena Vida-Navas, Verónica Barca-Tierno, Victoria López-Gómez

|Dec 23, 2022
Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study.

Manuel Valladares-Ayerbes, Pilar Garcia-Alfonso, Jorge Muñoz Luengo

|Mar 26, 2022
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.

Rocio Garcia-Carbonero, Miriam Bazan-Peregrino, Marta Gil-Martín

|Jul 13, 2021
Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial.

Bruno Bockorny, Teresa Macarulla, Valerya Semenisty

|Jan 26, 2020
SEOM clinical guideline on hereditary colorectal cancer (2019).

C Guillén-Ponce, E Lastra, I Lorenzo-Lorenzo

Pageof 2

Frequent Collaborators

2 joint publications

A Cervantes

2 joint publications

Bruno Bockorny

2 joint publications

Jaime Feliu

1 joint publications

A B Sánchez-Heras